President Trump Pauses Implementation of Tariffs for One Month

Published in Government Relations on February 04, 2025

On Monday, Feb. 3, President Donald Trump suspended his threat of imposing 25% tariffs on Mexico and Canada at the last minute, agreeing to a one-month pause in exchange for concessions on border security and crime enforcement. 

The proposed tariffs, announced by Trump on Saturday, included a 25% duty on all imports from Mexico and most imports from Canada, with a carve-out for a 10% tariff on energy products. Additionally, a new 10% tariff on Chinese goods was proposed. Trump mentioned earlier on Monday that he would be speaking with China soon. 

VGM Government Relations will provide updates as more information becomes available. 

Impact Of Tariffs On The DMEPOS Industry 

Published in Government Relations on Jan. 31, 2025 

President Donald Trump announced on Thursday that he will impose 25 percent tariffs on Canada and Mexico starting Saturday, Feb. 1. The durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry is closely monitoring the situation to see what, if any, exclusions might be included for medical equipment and products. An increase in tariffs could lead to several key impacts: 

  1. Increased Wholesale Costs: The cost of importing medical equipment from overseas will rise, impacting the overall expenses for DMEPOS providers. This increase in costs is likely to be passed on to consumers, leading to higher prices for medical devices and supplies. For instance, tariffs on Chinese-made medical devices could increase prices by up to 25%, affecting a wide range of products from syringes to diagnostic equipment. 
     
  2. Access To Medical Equipment: Higher costs may limit the availability of essential medical devices, making it harder for providers to maintain adequate supplies. This could particularly impact smaller providers who may struggle to absorb the increased costs. The tariffs could also lead to shortages of critical medical supplies, as providers may reduce their orders to manage costs. 
     
  3. Timely Delivery: The tariffs could exacerbate delays in the supply chain, similar to the disruptions experienced during the supply chain shortage in 2023. The previous shipping crisis had a significant impact on the access and cost of DMEPOS, causing delays and increased expenses. Similar challenges are anticipated with the new tariffs, as increased costs and potential retaliatory measures from affected countries could further disrupt the supply chain. 

What Can You Do Now? 

Providers may face increased financial pressure, which could affect their ability to deliver timely and affordable care to patients. The industry must prepare for these potential disruptions by: 

  • Exploring Alternative Supply Sources: Identify and establish relationships with new suppliers who are not affected by the tariffs. 
     
  • Increasing Inventory Levels: Stockpile essential medical supplies to buffer against potential shortages and delays. 
     
  • Advocating For Policy Changes: Engage with policymakers to advocate for measures that mitigate the impact of tariffs on essential medical supplies. 

VGM Government Relations will keep you updated as we learn more about this. 

From Our Experts

BOC Reinstated As Approved Accrediting Organization thumbnail BOC Reinstated As Approved Accrediting Organization As reported by HME News: Court grants company's motion for temporary restraining order against CMS OWINGS Mills, MD.—The Board of Certification/Accreditation (BOC) has been reinstated as an approved accrediting organization (AO) in all but four states, the company has announced. Click here to read the full article from HME News. The federal court has granted a temporary restraining order (“TRO”) in favor of BOC…thereby restoring BOC as an accrediting organization in all states except N DMEPOS Bills Gaining Momentum thumbnail DMEPOS Bills Gaining Momentum Fresh off a great House Energy & Commerce Health Sub-Committee hearing, now is the perfect time to reach out to your representative(s) and ask them to support the DMEPOS Relief Act, H.R. 2005; Choices for Increased Mobility Act of 2025, H.R. 1703; and the Supplemental Oxygen Access Reform Act of 2025, H.R. 2902. CMS Changes Competitive Bid Program Impacting Contracts and Bid Submission Requirements for Financial Documentation – What Providers Need to Know thumbnail CMS Changes Competitive Bid Program Impacting Contracts and Bid Submission Requirements for Financial Documentation – What Providers Need to Know The Centers for Medicare and Medicaid Services' (CMS) changes to the DMEPOS Competitive Bid Program as outlined in CMS-1828-F will reshape how suppliers prepare bids, qualify for contracts, and manage operational readiness. For DME suppliers, understanding both the changes to the contract awards and the bid submission is essential to understanding and preparing for the next bidding cycle. Meet The Candidates: VGM Hosts Rep. Randy Feenstra, Iowa Gubernatorial Candidate thumbnail Meet The Candidates: VGM Hosts Rep. Randy Feenstra, Iowa Gubernatorial Candidate Waterloo, Iowa – On Monday, VGM Group welcomed employees and local guests for another installment of its Meet The Candidates series. The featured guest was Rep. Randy Feenstra, current Congressman for Iowa's 4th District and a strong supporter of DMEPOS legislation. Energy & Commerce Health Subcommittee to Hold Hearing on Medicare Payment Policy Legislation – Thursday, Jan. 8 thumbnail Energy & Commerce Health Subcommittee to Hold Hearing on Medicare Payment Policy Legislation – Thursday, Jan. 8 The House Energy & Commerce Committee's Subcommittee on Health will hold a hearing titled “Legislative Proposals to Support Patient Access to Medicare Services” on Thursday, Jan. 8, at 10:15 a.m. (ET). CMS Releases CPI-U Adjustments for DMEPOS In 2026 And Fee Schedule Q1 thumbnail CMS Releases CPI-U Adjustments for DMEPOS In 2026 And Fee Schedule Q1 The Centers for Medicare & Medicaid Services (CMS) released the annual inflation factor to be applied to DMEPOS items effective January 1, 2026, with an implementation date of January 5, 2026. The breakdown of the adjustment is dependent upon whether the serviced items are included in the competitive bidding program (CBP) or are in formerly competitive bid areas (CBAs) such as rural and non-rural. Update from the Board of Certification/Accreditation thumbnail Update from the Board of Certification/Accreditation Yesterday, the Board of Certification/Accreditation (BOC) issued a clarification regarding the Centers for Medicare & Medicaid's (CMS) recent announcement about withdrawing BOC Accreditation. Here are the key updates... CMS Withdraws BOC Accreditation Authority For DMEPOS Suppliers thumbnail CMS Withdraws BOC Accreditation Authority For DMEPOS Suppliers On December 2, 2025, the Centers for Medicare & Medicaid Services (CMS) officially revoked the Board of Certification/Accreditation International (BOC) as an approved accreditation organization for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS).